Erratum: PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease (Am J Gastroenterol 110:846-856(2015) DOI: 10.1038/ajg.2015.137);PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease

American Journal of Gastroenterology

Volumn 110, Issue 6, 2015, Pages 846-856

  Salameh, Habeeb ^a   Raff, Evan ^b   Erwin, Angelika ^c   Seth, Devanshi ^d,e,f   Nischalke, Hans Dieter ^g   Falleti, Edmondo ^h   Burza, Maria Antonella ⁱ   Leathert, Julian ^j   Romeo, Stefano ^i,k   Molinaro, Antonio ⁱ   Corradini, Stefano Ginanni ^l   Toniutto, Pierluigi ^m   Ulrich, Spengler ^g   Daly, Ann ⁿ   Day, Christopher P ⁿ   Kuo, Yong Fang ^a   Singal, Ashwani K ^o  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b and Clinical Center   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e CENTENARY INSTITUTE   (Australia)

^f University of Sydney   (Australia)

^g UNIVERSITY OF BONN   (Germany)

^h UNIVERSITY HOSPITAL OF UDINE   (Italy)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m UNIVERSITY OF UDINE   (Italy)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o University of Alabama   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PATATIN LIKE PHOSPHOLIPASE DOMAIN PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; ALCOHOL; CENTRAL DEPRESSANT AGENT; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ALCOHOLIC LIVER INJURY; ARTICLE; DISEASE SEVERITY; ETHNICITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; CHEMICALLY INDUCED; DRUG-INDUCED LIVER INJURY; GENETICS; LIVER TUMOR; META ANALYSIS; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, HEPATOCELLULAR; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG-INDUCED LIVER INJURY; ETHANOL; FATTY LIVER, ALCOHOLIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPASE; LIVER CIRRHOSIS, ALCOHOLIC; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84930766891     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.137     Document Type: Erratum

References (50)

1. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann NY Acad Sci 1975;252: 85-105.
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141: 1572-85.
3. Reed T, Page WF, Viken RJ et al. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 1996;20: 1528-33.
4. Flores YN, Yee HF, Leng M et al. Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol 2008;103: 2231-8.
5. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003;27: 209-19.
6. Said A, Williams J, Holden J et al. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting. Clin Gastroenterol Hepatol 2004;2: 928-34.
7. Stickel F, Osterreicher CH. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 2006;41: 209-24.
8. Zintzaras E, Stefanidis I, Santos M et al. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology 2006;43: 352-61.
9. Romeo S, Kozlitina J, Xing C et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40: 1461-5.
10. Yuan X, Waterworth D, Perry JR et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008;83: 520-8.
11. Kollerits B, Coassin S, Kiechl S et al. A common variant in the adiponutrin gene influences liver enzyme values. J Med Genet 2010;47: 116-9.
12. Kotronen A, Johansson LE, Johansson LM et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009;52: 1056-60.
13. Kotronen A, Peltonen M, Hakkarainen A et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009;137: 865-72.
14. Sookoian S, Casta GO, Burgue AL et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009;50: 2111-6.
15. Romeo S, Sentinelli F, Dash S et al. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010;34: 190-4.
16. Kantartzis K, Peter A, Machicao F et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009;58: 2616-23.
17. Sato M, Kato N, Tateishi R et al. Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Hepatol Res 2014;44: E137-44.
18. Seth D, Daly AK, Haber PS et al. Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology 2010;51: 1463-5.
19. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283: 2008-12.
20. Wells GA, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [webpage on the Internet] Ottawa, ON: Ottawa Hospital Research Institute; 2011 [Accessed 10, 2014]. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
21. Minelli C, Thompson JR, Abrams KR et al. How should we use information about HWE in the meta-analyses of genetic association studies? Int J Epidemiol 2008;37: 136-46.
22. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 2009;169: 505-14.
23. Th akkinstian A, McElduff P, D'Este C et al. A method for meta-analysis of molecular association studies. Stat Med 2005;24: 1291-306.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-88.
25. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in metaanalyses. BMJ 2003;327: 557-60.
26. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG (eds) Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd (edn) BMJ Books: London, 2005, pp 285-312
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-101.
28. Hamza S, Petit JM, Masson D et al. PNPLA3 rs738409 GG homozygote status is associated with increased risk of hepatocellular carcinoma in cirrhotic patients. J Hepatol 2012;56 (Suppl 2): S281-82.
29. Way M, McQuillin A, Gurling HMD et al. The PNPLA3 I148M mutation significantly increases the risk of developing alcohol-related cirrhosis in alcohol-dependent individuals. J Hepatol 2013;58: S563-64.
30. Dutta AK. Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population. Ann Hepatol 2013;12: 901-7.
31. Nguyen-Khac E, Houchi H, Dreher M-L et al. Is PNPLA3 polymorphism involved in severe acute alcoholic hepatitis. Hepatology 2011;54: 976A.
32. Tian C, Stokowski RP, Kershenobich D et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet 2010;42: 21-3.
33. Tro E, Gustot T, Degr D et al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 2011;55: 906-12.
34. Nischalke HD, Berger C, Luda C et al. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS One 2011;6: e27087.
35. Stickel F, Buch S, Lau K et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 2011;53: 86-95.
36. Falleti E, Fabris C, Cmet S et al. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int 2011;31: 1137-43.
37. Rosendahl J, Tjes A, Schleinitz D et al. A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis. PLoS One 2012;7: e29433.
38. Trepo E, Guyot E, Ganne-Carrie N et al. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology 2012;55: 1307-8.
39. Guyot E, Sutton A, Rufat P et al. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J Hepatol 2013;58: 312-8.
40. Burza MA, Molinaro A, Attilia ML et al. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis. Liver Int 2014;34: 514-20.
41. Edmondson HA, Peters RL, Frankel HH et al. The early stage of liver injury in the alcoholic. Medicine (Baltimore) 1967;46: 119-29.
42. Naveau S, Giraud V, Borotto E et al. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25: 108-11.
43. Crabb DW. Pathogenesis of alcoholic liver disease: newer mechanisms of injury. Keio J Med 1999;48: 184-8.
44. Lane BP, Lieber CS. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol 1966;49: 593-603.
45. Tang-Barton P, Vas W, Weissman J et al. Focal fatty liver lesions in alcoholic liver disease: a broadened spectrum of CT appearances. Gastrointest Radiol 1985;10: 133-7.
46. Singal AG, Manjunath H, Yopp AC et al. The Effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am J Gastroenterol 2014;109: 325-34.
47. Chamorro AJ, Torres JL, Miron-Canelo JA et al. Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Aliment Pharmacol Ther 2014;40: 571-81.
48. Tro E, Nahon P, Bontempi G et al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 2014;59: 2170-7.
49. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53: 207-16.
50. Zou GY, Donner A. The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: a cautionary note. Ann Hum Genet 2006;70: 923-33.